About Nexcelom Bioscience
Nexcelom Bioscience is a company based in Lawrence (United States) founded in 2003 was acquired by PerkinElmer in May 2021. Nexcelom Bioscience offers products and services including Cellometer Ascend, Cellaca PLX, and ViaStain AOPI. Nexcelom Bioscience operates in a competitive market with competitors including Halo Labs, Spheryx, Biotrack, TACount and Spectradyne, among others.
- Headquarter Lawrence, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Revvity, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
PerkinElmer
& 1 more
-
Employee Count
Employee Count
-
Acquired by
PerkinElmer
(May 12, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nexcelom Bioscience
Nexcelom Bioscience offers a comprehensive portfolio of products and services, including Cellometer Ascend, Cellaca PLX, and ViaStain AOPI.
Device for fast and accurate cell counting in research applications
High-throughput system for assessing cell health and viability
Staining solution for cell viability and analysis in assays
People of Nexcelom Bioscience
Unlock access to complete
Unlock access to complete
Funding Insights of Nexcelom Bioscience
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2018 | Amount | Private Equity Round - Nexcelom Bioscience | Valuation |
investors |
Investors in Nexcelom Bioscience
Nexcelom Bioscience has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include PerkinElmer and Ampersand Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
|
Founded Year | Domain | Location | |
|
Medical instruments and supplies are manufactured and provided for healthcare.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nexcelom Bioscience
Financial Statements - Nexcelom Bioscience
Nexcelom Bioscience Comparisons
Competitors of Nexcelom Bioscience
Nexcelom Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Halo Labs, Spheryx, Biotrack, TACount and Spectradyne, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of subvisible particle analyzer for life science and materials applications
|
|
| domain | founded_year | HQ Location |
Analytical instruments company developing instruments for non-destructive, quantitative measurements of suspended particles
|
|
| domain | founded_year | HQ Location |
Rapid microbial detection and identification system
|
|
| domain | founded_year | HQ Location |
Specializes in imaging-based technology for microbiological testing.
|
|
| domain | founded_year | HQ Location |
Nano-particle counters are manufactured for research and biomedical uses.
|
Frequently Asked Questions about Nexcelom Bioscience
Nexcelom Bioscience was founded in 2003 and raised its 1st funding round 15 years after it was founded.
Nexcelom Bioscience is headquartered in Lawrence, United States. It is registered at Lawrence, Kansas, United States.
Founded in 2003 and based in Lawrence, United States, operations focus on the biotechnology sector through the development, manufacturing, and marketing of image-based cytometry tools. Products such as the Cellometer automated counters and Celigo imaging cytometer are utilized for cell analysis and viability assessments in both attached and suspension cells. Fluorescent reagents, kits, disposable hemocytometers, counting chambers, and low-adhesion plates are also provided to support cell-based assays.
Nexcelom Bioscience's top competitors include Halo Labs, Spheryx and Spectradyne.
Nexcelom Bioscience offers Cellometer Ascend, Cellaca PLX, and ViaStain AOPI.
Nexcelom Bioscience has 2 investors. Key investors include PerkinElmer, and Ampersand Capital Partners.